Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
about
Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Aberrant Promoter Methylation ...... cance in Renal Cell Carcinoma.
@en
type
label
Aberrant Promoter Methylation ...... cance in Renal Cell Carcinoma.
@en
prefLabel
Aberrant Promoter Methylation ...... cance in Renal Cell Carcinoma.
@en
P2093
P2860
P356
P1476
Aberrant Promoter Methylation ...... cance in Renal Cell Carcinoma.
@en
P2093
Hong-Zhao Li
Ying-Li Lin
Yun-Peng Wang
P2860
P304
P356
10.12659/MSM.902077
P577
2017-07-08T00:00:00Z